As if a huge debt, a sagging share price, weakened sales and a variety of regulatory problems aren’t enough, a jury has ordered Boston Scientific (Natick, Massachusetts) to pay $431 million in damages to Dr. Bruce Saffran, a New Jersey radiologist who charged that the medical device maker's drug-eluting stents (DES) infringe a patent that he received in 1997.